Armistice Capital’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-181,500
| Closed | -$2.59M | – | 72 |
|
|
2019
Q2 | $2.59M | Buy |
181,500
+5,833
| +3% | +$83.3K | 0.16% | 50 |
|
|
2019
Q1 | $5.78M | Buy |
175,667
+70,834
| +68% | +$2.33M | 0.32% | 48 |
|
|
2018
Q4 | $6.23M | Buy |
104,833
+7,833
| +8% | +$465K | 0.47% | 41 |
|
|
2018
Q3 | $13.6M | Sell |
97,000
-28,000
| -22% | -$3.93M | 0.82% | 31 |
|
|
2018
Q2 | $15.3M | Buy |
125,000
+50,000
| +67% | +$6.14M | 1% | 26 |
|
|
2018
Q1 | $6.71M | Sell |
75,000
-3,000
| -4% | -$268K | 0.51% | 45 |
|
|
2017
Q4 | $4.32M | Buy |
78,000
+46,333
| +146% | +$2.57M | 0.43% | 48 |
|
|
2017
Q3 | $1.34M | Buy |
+31,667
| New | +$1.34M | 0.16% | 52 |
|
|
2017
Q2 | – | Sell |
-9,333
| Closed | -$522K | – | 60 |
|
|
2017
Q1 | $522K | Buy |
+9,333
| New | +$522K | 0.11% | 43 |
|